Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002637777 | SCV003518227 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004070795 | SCV005033031 | uncertain significance | Cardiovascular phenotype | 2024-02-05 | criteria provided, single submitter | clinical testing | The p.R1169W variant (also known as c.3505C>T), located in coding exon 26 of the JAG1 gene, results from a C to T substitution at nucleotide position 3505. The arginine at codon 1169 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear. |